ASCO Conference Coverage
Filter News By:
Featured News
View all
More News
(ACCCBuzz Blog) June 12, 2020 - At the recent American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program, ACCC presented seven abstracts that capture data spanning the organization’s diverse provider education...
(Johns Hopkins) June 10, 2020 - Johns Hopkins Kimmel Cancer Center thoracic cancer and cancer genomics experts reported promising new findings and studies in mesothelioma, lung cancer and melanoma at the annual meeting of the American...
(MedPage Today) June 8, 2020 - Consensus on testing for dMMR/MSI-H, but strategies vary for other biomarkers.
(Medscape Medical News) June 8, 2020 - Continuing adjuvant imatinib (Gleevec, Novartis) for 3 years rather stopping at 1 year in patients with high-risk gastrointestinal stromal tumor (GIST) could halve the death rate over 10 years,...
(BioPharma Dive) June 5, 2020 - The China-based cell therapy developer, whose myeloma therapy is a rival to one from Bristol Myers and Bluebird, outraised this year's previous top initial biotech stock offering.
(Medscape Medical News) June 4, 2020 - The world's largest oncology meeting went online to mixed reviews. Doubts and hopes coexist about an in-person meeting next year.
(MedPage Today) June 3, 2020 - Response rates of 70-100% with BCMA-targeted products for heavily treated disease.
(MedPage Today) June 3, 2020 - Overall response rate of 36% with tumor-infiltrating lymphocytes in heavily treated patients.
(UPI/HealthDay News) June 3, 2020 - Screening for breast and ovarian cancer genes might be added to the list of medical tests that can be safely and effectively done from home, new research suggests.
(WebMD/Medscape Medical News) June 2, 2020 - The proton pump inhibitor (PPI) omeprazole used with chemotherapy may help shrink tumors in patients with triple-negative breast cancer.
Expert Videos

OBR Tweets

Aug 04
William McGivney, PhD: It is interesting to see "record profits" for managed care companies in the face of the Covi… https://t.co/rT8cnBEEZu

Jul 27
Dean Gesme, MD: Trump gave just Congress and manufacturers 30 days to develop and pass a Part B Medicare drug acqui… https://t.co/pK6VjPFbo0

Jul 24
A panel of three breast cancer experts looked at some of the big studies at #ASCO20 and discussed treatment advance… https://t.co/ZcPRjbtKvL

Jul 24
OBR spoke at length with ASCO's president, Dr. Howard "Skip" Burris, about the pros and cons of #ASCO20's virtual f… https://t.co/9Bq8oJfj5c

Jul 23
A lack of interoperability in the nation's healthcare system has detracted from patient care, leading to poor healt… https://t.co/t6o30WgMjU

Jul 20
William McGivney, PhD: It is with fondness and a smile that I read the story about the distress thermometer now bei… https://t.co/oWDatBpFnu

Jul 15
H. Jack West, MD: Unclear to me why this doesn't raise alarm bells as a conflict of interest. Why is an institution… https://t.co/7pAHP6YnWx

Jul 09
H. Jack West, MD: The benefit of low dose chest CT screening for lung cancer remains somewhat controversial, but th… https://t.co/8wOgsSCY7q

Jul 08
Howard S. Hochster, MD: While a "complete response" is great for our patients, the Complete Response Letter was les… https://t.co/yQGkfvpMCF

Jul 02
A panel of three breast cancer experts looked at some of the big studies at #ASCO20 and discussed treatment advance… https://t.co/ve0XD0cWDY